Related Experiment Videos
[Colonization by pyocyanic bacillus and its treatment in cystic fibrosis]
1Département de pédiatrie, hôpital Necker-Enfants-Malades, Paris.
Abstract:
In cystic fibrosis infection is localized to the bronchi and self-perpetuated by a disorder of mucociliary clearance. At a certain stage of the disease infection is caused by Pseudomonas aeruginosa (PA), and the patient cannot get rid of it as cystic fibrosis reduces his defence mechanisms against this organism, a naturally weak pathogen. The presence and significance of persistent bronchial PA infection result from complex phenomena which have been summarized as "an opportunistic organism in a host whose defences have been very peculiarly compromised". The toxicity of PA and the inappropriate inflammatory response of the host concur to create permanent alveolar lesions which are gradually spreading out. The effectiveness of antibiotics depends on the organism and its resistance, on pharmacokinetic factors bringing the drug in situ and on local conditions of redox, physico-chemical environment and nutrition. Other factors intervene more roughly, including patient's age, liver impairment, lung anatomy (excluded areas), general malnutrition and vitamin deficiencies. Thus, the part played by other treatments in the antibiotic therapy of cystic fibrosis can no longer be ignored, just as it is no longer sensible to limit the use of antibiotics to obvious infections. To evaluate the effectiveness of antibiotics is not easy, but it can be demonstrated beyond any doubt when the above mentioned factors are taken into account. The use of antibiotics creates practical problems relating to their cost, their dosage, their side-effects, the adequacy of therapeutic infrastructures and, above all, it raises the question of short- and long-term changes in microbial ecology.
Insights
Cystic fibrosis patients struggle with Pseudomonas aeruginosa (PA) infections due to compromised defenses. Effective antibiotic treatment requires considering various host and drug factors beyond just the pathogen.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Microbiology
Background:
- Cystic fibrosis (CF) involves persistent bronchial infections, primarily Pseudomonas aeruginosa (PA).
- PA is an opportunistic pathogen thriving in CF patients with compromised immune defenses.
- Chronic PA infection leads to progressive lung damage via bacterial toxins and host inflammation.
Purpose of the Study:
- To analyze the complex factors influencing antibiotic effectiveness in cystic fibrosis patients with Pseudomonas aeruginosa infections.
- To highlight the need for a comprehensive approach to antibiotic therapy in CF, considering host-specific and environmental variables.
Main Methods:
- Review of existing literature on Pseudomonas aeruginosa infections in cystic fibrosis.
- Analysis of factors affecting antibiotic efficacy, including pharmacokinetics, host defenses, and local lung environment.
- Consideration of patient-specific conditions like age, nutritional status, and co-morbidities.
Main Results:
- Antibiotic effectiveness is multifactorial, influenced by pathogen resistance, drug delivery, and the host's local environment (redox, nutrition).
- Patient-specific factors such as age, liver function, lung anatomy, malnutrition, and vitamin deficiencies significantly impact treatment outcomes.
- Evaluating antibiotic effectiveness requires a holistic approach, accounting for numerous interacting variables.
Conclusions:
- Optimizing antibiotic therapy for Pseudomonas aeruginosa in cystic fibrosis necessitates a personalized approach, integrating host factors and environmental conditions.
- Non-antibiotic treatments and strategies addressing host defenses are crucial adjuncts to antimicrobial therapy.
- The long-term use of antibiotics raises concerns regarding microbial ecology shifts and necessitates careful consideration of cost, dosage, and side effects.